Received Jun 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y003883 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y015108 | — |
No additional AE/PQC reported; HCP reported that a husband and wife both received the VARIVAX and PROQUAD vaccines concomitantly; HCP reported that both patients are adults; This spontaneous report was received from a medical assistant and refers to an adult female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 20-May-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), lot #Y015108, expiration date: 06-Sep-2026 (exact dose, route of administration and anatomical location were not provided) for prophylaxis. On 20-May-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), lot #Y003883, expiration date: 05-Aug-2025 (exact dose, route of administration and anatomical location were not provided) for prophylaxis. The vaccines were reconstituted with sterile diluent (MERCK STERILE DILUENT) (product administered to patient of inappropriate age, overdose). No additional adverse event reported (no adverse event).
Sterile diluent